Clarivate (NYSE:CLVT) Shares Up 7.3% – Here’s Why

Clarivate PLC (NYSE:CLVT) shot up 7.3% during mid-day trading on Tuesday . The company traded as high as $2.25 and last traded at $2.2850. Approximately 526,768 shares were traded during trading, a decline of 92% from the average session volume of 6,739,806 shares. The stock had previously closed at $2.13.

Analyst Ratings Changes

A number of research analysts have recently weighed in on CLVT shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Clarivate in a research report on Wednesday, June 24th. Wall Street Zen raised Clarivate from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Finally, Barclays lifted their price objective on Clarivate from $2.40 to $2.50 and gave the stock an “underweight” rating in a report on Tuesday, July 7th. Four analysts have rated the stock with a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Reduce” and an average target price of $2.98.

Clarivate Stock Performance

The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.84 and a current ratio of 0.84. The firm’s 50 day moving average is $2.29 and its 200-day moving average is $2.45. The company has a market cap of $1.54 billion, a PE ratio of -11.45 and a beta of 1.38.

Clarivate (NYSE:CLVT) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of $0.14 by $0.04. Clarivate had a positive return on equity of 8.82% and a negative net margin of 5.61%.The company had revenue of $585.50 million for the quarter, compared to analyst estimates of $569.50 million. During the same quarter in the previous year, the company posted $0.14 earnings per share. The firm’s revenue for the quarter was down 1.4% compared to the same quarter last year. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. On average, research analysts anticipate that Clarivate PLC will post 0.65 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Clarivate

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CLVT. Atairos Partners GP Inc. lifted its stake in shares of Clarivate by 195.3% in the 4th quarter. Atairos Partners GP Inc. now owns 10,232,667 shares of the company’s stock valued at $34,177,000 after purchasing an additional 6,767,667 shares during the last quarter. First Trust Advisors LP purchased a new stake in Clarivate in the 4th quarter valued at about $16,721,000. Balyasny Asset Management L.P. lifted its position in Clarivate by 827.6% in the third quarter. Balyasny Asset Management L.P. now owns 4,882,593 shares of the company’s stock valued at $18,700,000 after buying an additional 4,356,232 shares during the last quarter. Bank of America Corp DE boosted its stake in Clarivate by 506.9% during the second quarter. Bank of America Corp DE now owns 2,870,668 shares of the company’s stock worth $12,344,000 after buying an additional 2,397,670 shares during the period. Finally, Man Group plc boosted its stake in Clarivate by 228.1% during the second quarter. Man Group plc now owns 3,091,139 shares of the company’s stock worth $13,292,000 after buying an additional 2,148,943 shares during the period. Institutional investors and hedge funds own 85.72% of the company’s stock.

About Clarivate

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.